Our ‘quick’ screen program was developed to enable our biopharmaceutical clients to obtain a preliminary dataset across assay platforms in a cost-effective manner. Our assays and models are designed to address function and mechanism of action with the intent of facilitating the decision making process on which drug candidates to carry forward.

Advantages

  • Cost-effective – “stitch” together a robust dataset across platforms
  • Preliminary proof-of-concept (Go/No Go)
  • Compliment internal data or results
  • Access to versatile assays and model systems across diseases

HOW CAN WE WORK WITH YOU?

null

OUTSOURCE

For partners with limited resources, our team can help pull together the “tools” necessary to screen your drug candidates.
null

CONFIRM

Have you generated internal results? Let us independently confirm your results with our cell platforms.
null

PARTNERSHIP

For virtual biotechs – we think alike. We know the meaning of being capital efficiency. Let us handle your IO translational work.

Our capabilities

Our infrastructure is equipped with state-of-the-art equipment necessary to conduct any preclinical research studies.

Leadership

Our team has a history of working together and we bring a collective
expertise in helping our clients achieve their goals.

Please Contact Us to be added to our Quick Screen Assay mailing list